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A B S T R A C T
Objective: To identify autonomic dysregulation in frontal lobe epilepsy (FLE).
Methods: We studied 14 male and 11 female subjects with FLE and an equal number of matched healthy
control subjects. Lead I electrocardiograms were obtained for 5 min in the interictal state during daytime.
Frequency-domain analysis of heart rate variability was performed and the data subsequently converted
to heart rate interval and high frequency (HF; 0.15–0.45 Hz) power which representing vagal or
parasympathetic regulation, as well as low frequency (LF; 0.04–0.15 Hz) power and LF/(HF + LF)
expressed in normalized units (LF%) (considered to mirror sympathetic regulation). Differences in data
between groups were compared using t-test.
Results: The epilepsy group had a lower mean heart rate interval and a lower high frequency power.
Conclusions: Patients with FLE have interictally faster heart rates, attributed to lower parasympathetic
drive, which may contribute to the higher incidence of sudden death that is seen in this group of patients.
This suggests that themechanism of decreased HRV in patients with FLE is probably different from that in
patients with temporal lobe epilepsy.
 2008 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Impaired autonomic regulation and cardiac arrhythmia are not
uncommon in humans with epilepsy.1,2 Dysregulation of auto-
nomic nervous system (ANS) has been associated with long-term
morbidity and mortality in epileptic patients.3,4 Sudden unex-
pected death in epileptic patients (SUDEP) is now known to be
associated with ANS dysregulation of the heart.3,5 Previous studies
of ANS in epilepsy were mostly conﬁned to temporal lobe epilepsy
(TLE) and uncovered mainly sympathetic dysregulation.1,4 In TLE,
most researchers believe that lesions of the insular cortex lead to
the ANS dysregulation6 and temporal lobe resection has been
shown to decrease sympathetic and cardiac dysregulation.7
The frontal lobe is the second most common site of origin of
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doi:10.1016/j.seizure.2008.05.013study, insular area was found to link with multiple regions in the
frontal lobe.9 Seizures of frontal lobe origin are of highly variable
types and autonomic symptoms during these seizures have often
been reported in literature.8,10 However, autonomic function in
patients with frontal lobe epilepsy (FLE) has rarely been studied
and the mechanism of sympathetic and parasympathetic regula-
tion of the heart in these patients remains to be clariﬁed.
Frequency-domain analysis of heart rate variability (HRV) is a
sophisticated and noninvasive tool for studying neural regulation
of heart rate. The standard procedures and interpretation of HRV
analysis were ﬁrst reported in 1996.11 We used a modiﬁcation of
this procedure12 in this study to evaluate sympathetic and
parasympathetic regulation of heart rate in patients with FLE.
Methods
Epileptic patients and controls
Fourteen males and 11 females (age 5–34 years; mean age:
16.16 years) who had epilepsies of frontal lobe origin as identiﬁed
by interictal electroencephalography (EEG)were enrolled. For eachvier Ltd. All rights reserved.
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seizure types according to International League Against Epilepsy
guidelines (ILAE, 1981). Brain magnetic resonance imaging was
used to detect possible structural lesions and EEG was used to
determine epileptogenic zones. Clinical features of our epileptic
patients are reported in Table 1. None of the patients had
arrhythmia, systemic disease, or adverse effects to therapy. Patient
numbers 9 and 21 had intracranial arachnoid cysts but the cysts
did not correlate with their seizure foci. All patients were classiﬁed
as idiopathic or cryptogenic epilepsies.
Healthy controls comprised 14 males and 11 females subjects
(mean age: 16.20 years). The two groups were well-matched for
anthropometric characteristics, such as gender, age, weight,
height, and body mass index (BMI).
Experimental protocols
At enrollment, each subject underwent a daytime electro-
cardiogram (ECG) in awake interictal state after an informed
consent was obtained. The ECG was recorded for 5 min while each
subject lay quietly in a 458 head-up posture and breathed
normally. Lead I ECG signals were retrieved using an analog-to-
digital converter with a sampling rate of 512 Hz. The digitized ECG
signals were analyzed on-line andwere simultaneously stored on a
hard disk for off-line analysis.12
Processing of ECG signals
The digitized ECG signals were stored for off-line veriﬁcation.
Signal acquisition, storage, and processing were performed on an
IBM-compatible personal computer. Our computer algorithm
then identiﬁed each QRS complex and rejected each ventricular
premature complex or noise according to its resemblance to a
standard QRS template. Stationary R–R values were resampled
and interpolated at a rate of 7.11 Hz to provide continuity in the
time-domain.12Table 1
Clinical features of patients with frontal lobe epilepsy
Patients (no.) Age (years)/
gender
Duration of
epilepsy (years)
Type of seizures Interict
1 7/F 7 Tonic, tonic–clonic Spikes,
2 7/F 4 Tonic, tonic–clonic Spike/p
3 8/F 2 Tonic Spikes,
4 9/F 3 Tonic Repeat
5 13/F 8 CPS, sec. GTC Polyspi
6 14/F 13.5 Tonic–clonic Paroxy
7 15/F 10 Tonic–clonic Polymo
8 16/F 15 Tonic, tonic–clonic Spikes,
9 5/M 2 Tonic–clonic Trains
10 8/M 2 PS Sharp w
11 10/M 4 Tonic–clonic Slow w
12 15/M 10 Tonic–clonic Spikes
13 19/M 15 CPS, sec. GTC Repeat
14 25/M 10 Tonic–clonic Sharp-c
15 27/M 24 CPS, sec. GTC Isolated
16 31/M 28 Tonic–clonic Spike-w
17 32/M 14 CPS Isolated
18 8/F 5 Tonic–clonic, absence Spikes,
19 16/F 7 Tonic–clonic Spike/p
20 23/F 2 CPS Spikes
21 12/M 6 CPS, sec. GTC Spikes
22 16/M 8 Tonic Sharp w
23 16/M 10 CPS Transie
24 18/M 8 CPS, sec. GTC Polyspi
25 34/M 31 CPS, sec. GTC Spikes
EEG, electroencephalography; CPS, complex partial seizure; sec. GTC, secondarily genera
sodium valproate; LTG, lamotrigine; PB, phenobarbital; PHT, phenytoin; TPM, topiramate
9 and no. 21 had intracranial arachnoid cysts which did not correlate with their seizuFrequency-domain analysis of HRV
Frequency-domain analysis was performed using a nonpara-
metric method of fast Fourier transformation (FFT). The direct
current component was deleted and a Hamming window was
used to attenuate the leakage effect. For each time segment (288 s;
2048 data points), our algorithm estimated the power spectrum
density on the basis of FFT. The resulting power spectrum was
corrected for attenuation resulting from the sampling and the
Hamming window.12 The power spectrum was subsequently
quantiﬁed into standard frequency-domain measurements as
deﬁned by the Task Force of the European Society of Cardiology
and the North American Society of Pacing and Electrophysiol-
ogy.11,12 These included the R–R intervals (the intervals between
two neighboring Rwaves, RR), high frequency (HF; 0.15–0.45 Hz)
power and low frequency (LF; 0.04–0.15 Hz) power. The LF
component is formed by both sympathetic and parasympathetic
contributions. The HF component is equivalent to the respiratory
sinus arrhythmia (RSA) and is considered to reﬂect vagal
(parasympathetic) regulation of the heart.11 The fraction LF/
(HF + LF) expressed as a normalized unit (LF%) is considered to
mirror sympathetic regulation.11 Due to that change of RR might
be proportionally linked to HF or LF in algorithm, we calculated
high frequency unit (HF/RR2  1002, HU) and low frequency unit
(LF/RR2  1002, LU) for further correction. The HF, LF, HU and LU
data were logarithmically transformed to correct for any skew in
the distribution.
Statistical analysis
Data are presented as mean  standard error (S.E.). The
signiﬁcance of differences between groups was examined using
Student’s t-test for independent continuous variables. If the datawere
far from normal distribution, the Mann–Whitney Rank Sum test was
applied instead. All statistical assessments were two-sided and
evaluated at the 0.05 level of signiﬁcant difference.al EEG ﬁndings, location Therapy at enrollment
sharp waves, spike-wave complexes, left F CZP, LTG, PB
olyspike-wave complexes, right F LTG, VPA
spike-wave complexes, left lateral frontal region TPM, VPA
ed or isolated spikes, spike-waves, left F TPM, VPA
kes and spike-wave complexes, left F OXC, VPA
sms of sharp-wave complexes, left F VPA
rphic alpha/theta activity, left F LTG, VPA
right frontocentral region PB, PHT, TPM
of sharply contoured 10–11 Hz activity, bilateral F OXC
ave with following rhythmic theta activity, left F CZP
aves, right frontocentral region VPA
with phase reversal, left frontocentral region VPA
ed spikes and polyspikes with phase reversal, right F CLB, VPA
ontoured alpha and semirhythmic theta activity, left F OXC
spikes, left lateral frontal region CZP, LTG, VPA
ave complexes and repetitive spikes, left F VPA
spikes, left F OXC
bilateral F CBZ, VPA
olyspike with phase reversal, left F CBZ, TPM
with phase reversal, left F CBZ
with phase reversal, bilateral frontocentral regions CBZ
aves with phase reversal, right F CBZ, VGB
nts of fast alpha activity or sharp waves, left F CBZ, VGB
kes, repeated spikes, spike-wave complexes, right F CBZ
with phase reversal, left F CBZ, LTG, VPA
lized tonic–clonic; PS, partial seizure; F, frontal location; OXC, oxcarbazepine; VPA,
; CZP, clonazepam; CLB, clobazam; CBZ, carbamazepine; VGB, vigabatrin. Patient no.
re foci. All the patients were categorized as idiopathic or cryptogenic epilepsy.
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Clinical features of epileptic patients
Table 1 demonstrates the clinical features of our patients. All
the 25 patients had idiopathic or cryptogenic epilepsies (duration
range 2–31 years, mean  S.E.: 9.94  1.57 years). Eight patients
were reported to have generalized tonic–clonic seizures (GTC) only.
Six patients had generalized tonic seizures (GT) but 3 of themhadGTC
as well. Complex partial seizures (CPS) were noted in 9 patients and
secondary generalization occurred in 6 patients. Patient no. 10 had
partial seizure (PS) only and patient no. 18 presented with GTC and
absence.Fig. 1. Age, height, weight, BMI, RR, LF, LF%, HF, LU and HU of control (Con) and frontal l
interval between 2 neighboring R waves; LF, low frequency power; LF%, LF/(HF + LF) expre
frequency unit. *P < 0.05 vs. control group by Student’s t-test.Epileptogenic foci on interictal EEGwere: left frontal in 16, right
frontal in 6 and bilateral frontal in 3 patients.
Eleven patients were treated with only one anti-epileptic drug
(AED): sodium valproate (4 patients), oxcarbazepine (3), clonaze-
pam (1), and carbamazepine (3). Ten patients received two AEDs:
lamotrigine and sodium valproate (2), topiramate and sodium
valproate (2), oxcarbazepine and sodium valproate (1), clobazam
and sodium valproate (1), carbamazepine and sodium valproate
(1), carbamazepine and topiramate (1), carbamazepine and
vigabatrin (2). Four patients considered resistant to a two-drug
combination received three AEDs each: clonazepam, lamotrigine,
and phenobarbital (1); Phenobarbital, phenytoin and topiramate
(1); clonazepam, lamotrigine, and sodium valproate (2).obe epilepsy (FLE) groups. Data expressed as mean  S.E. BMI, body mass index; RR,
ssed in normalized unit; HF, high frequency power; LU, low frequency unit; HU, high
Table 2
Comparisons of anthropometric characteristics and heart rate variables between
with and without carbamazepine (CBZ) using groups
With CBZ (5M, 3F) Without CBZ (9M, 8F) P-Value
Age (years) 17.88  2.77 15.35  2.1 0.268
Height (cm) 159.13  6.84 149.82  4.7 0.449
Weight (kg) 54.25  5.65 49.06  5.52 0.568
Duration of
epilepsy (years)
9.63  3.17 10.09  1.84 0.727
RR (ms) 747.5  21.17 659.65  25.08 0.037*
LF (ln(ms2)) 6.23  0.34 5.75  0.22 0.241
LF% (nu) 56.75  6.03 55.06  3.5 0.799
HF (ln(ms2)) 5.49  0.62 5.09  0.27 0.498
Data expressed as mean  S.E.; *P < 0.05.
Table 3
Comparisons of anthropometric characteristics and heart rate variables between
poly- and mono-therapy groups
Polytherapy (5M, 9F) Monotherapy (9M, 2F) P-Value
Age (years) 15.07  2.09 17.55  2.75 0.622
Height (cm) 151.29  5.4 154.73  5.81 0.784
Weight (kg) 48.93  5.35 53.0  6.68 0.634
Duration of
epilepsy (years)
10.64  2.2 9.05  2.32 0.625
RR (ms) 662.93  22.37 719.36  34.05 0.164
LF (ln(ms2)) 5.72  0.28 6.13  0.22 0.291
LF% (nu) 53.86  3.73 57.82  5.01 0.523
HF (ln(ms2)) 5.09  0.4 5.38  0.33 0.597
Data expressed as mean  S.E.
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Fig. 1 demonstrates anthropometric and heart rate variables in
patients with FLE and controls. Between-group differences in RR
and HF power (P < 0.05) but not age, height, weight, BMI, LF, LF%,
HU and LU were signiﬁcant (P > 0.05). As a group, the patients had
a signiﬁcantly lower mean heart rate interval (687.76 ms vs.
780.15 ms; P = 0.008) and HF power (5.22 ln[ms2] vs. 5.96 ln[ms2];
P = 0.043).
In Table 2, we divided patients into carbamazepine (CBZ) using
group and non-CBZ using group. The CBZ using group had a
signiﬁcantly higher mean heart rate interval (747.5 ms vs.
659.65 ms; P = 0.037) comparing to non-CBZ using group. There
was no signiﬁcant between-group difference in other heart rate
variables and anthropometric characteristics.
In Table 3, we divided patients into polytherapy group and
monotherapy group. There was no signiﬁcant difference in
anthropometric and heart rate variables between poly- and
mono-therapy groups.
Discussion
Autonomic dysregulation and SUDEP have been described not
only in TLE but also other forms of epilepsy.3,13 We believe that
HRV could be used to indicate the risk of SUDEP and guide the
treatment of epileptic patients. Our study conﬁrms that FLE with
repetitive seizures causes change in interictal cardiac autonomic
function. Faster heart rates or lower heart rate intervals in our
patients with FLE were found to correspond to lower parasympa-
thetic regulation rather than higher sympathetic drive. Although
it has been believed for the last 10 years that increased
sympathetic activity accounts for cardiac tachyarrthymia and
SUDEP in TLE,7 a recent study found decreased parasympathetic
drive in addition to increased sympathetic drive in some
patients.4Since increased sympathetic drive is believed to underlie
SUDEP, most researchers have favored treatments directed
towards reducing sympathetic activity.14,15 In one study, increas-
ing parasympathetic or vagal activity was shown to protect against
sudden death by suppressing atrial or ventricular ﬁbrillation.16
Taken together with our report, these reports suggest that risk of
SUDEP probably could be higher in patients with FLE and is likely
due to lower parasympathetic drive. When we calculated the HU
for further correction of parasympathetic index from the possible
effect of decreased RR in algorithm, a lower HU without
signiﬁcance (P = 0.138) was noted in FLE group when compared
with controls. However, the concomitant decrease of parasympa-
thetic regulation and heart rate interval is a known phenomenon in
current physiology and the HF is still thought to represent
parasympathetic index by most researchers.11
In this study, our results were limited by a relatively small
sample size and lack of uniformity. Some patients were included
who (1) were receiving CBZ which has been reported to affect
autonomic regulation in epileptic patients15 (2) suffered different
seizure types arising from different locations within the frontal
lobe. All of these factors could conceivably affect the results. In
subgroup analyses of our patients, CBZ using group vs. non-CBZ
using group or polytherapy group vs. monotherapy group did not
have any signiﬁcant between-group differences in sympathetic or
parasympathetic indices.Wemight conductmore studies to clarify
the confounding effects of AEDs on HRV of epileptic patients in the
future.
GTC was the most common seizure type in our patients with
FLE. Eighteen patients (72%) were reported with GTC but 6 of them
(24%) suffered CPS with secondarily generalized tonic–clonic
seizures. Three (12%) had GT and 1 (4%) of the patients had absence
besides GTC. GTC is known as the seizure type most often found to
cause autonomic dysregulation and increase risk of SUDEP.2,13 The
frontal lobe have extensive neural link9 and the spread of seizure
activities from frontal lobe foci10 to other brain regions and
autonomic centers can result in dysregulation of ANS.Which offers
a possible explanation for both the higher incidence of GTC and
impaired HRV in our patients.
HRV varies widely in healthy subjects,11 possibly due to effects
of circadian rhythms,17 gender,12 age,12 weight18 and body mass
index.19 In this study, all interictal heart rates were recorded
during the daytime to avoid major circadian effects, and
anthropometric factors known to affect HRV were excluded by
careful selection of controls. Since there were no signiﬁcant
between-group differences in these circadian and anthropometric
characteristics, we believe our study more accurately reﬂects the
effect of frontal lobe epilepsy on HRV.
A 24-h ECG recording provides information on circadian
changes of HRV in a patient and is considered to be a standard
procedure. However, 5-min ECG recordings have the advantage
that they can be performed repetitively in a ward, clinic, hospice,
or even the patient’s home to minimize the effects on ANS
regulation resulting from the stress from the study itself. The
digitized data ﬁle of a 5-min recording is relatively small and can
even be transmitted over the Internet for a remote analysis. This
technology is especially valuable in patients who are uncoopera-
tive or unwilling to undergo 24-h monitoring of ECG with analysis
of HRV.20 It is highly assessable and a positive result can suggest a
further 24-h recording of ECGwith analysis of circadian changes of
HRV.
Conclusions
Our data indicate that patients with frontal lobe epilepsy have
shorter interictal heart rate intervals and faster heart rates, which
T. Harnod et al. / Seizure 18 (2009) 21–25 25we postulate might be due to lower parasympathetic or vagal
regulation of autonomic cardiac activity. This suggests that the
mechanism of decreased HRV in patients with FLE is probably
different from that in patients with TLE. However, future work on
autonomic regulation in a larger number of subjects with FLE may
help elucidate the pathophysiological details for autonomic
dysregulation in frontal lobe epilepsy.
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